Shanghai Runda Med Tech Co (603108) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.028x

Based on the latest financial reports, Shanghai Runda Med Tech Co (603108) has a cash flow conversion efficiency ratio of 0.028x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥144.38 Million ≈ $21.13 Million USD) by net assets (CN¥5.15 Billion ≈ $752.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 603108 net asset quality index to measure how much of total assets are equity-financed.

Shanghai Runda Med Tech Co - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Shanghai Runda Med Tech Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 603108 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Shanghai Runda Med Tech Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Runda Med Tech Co ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Gubra A/S
CO:GUBRA
-0.519x
Zhejiang Tiantie Industry Co Ltd
SHE:300587
0.002x
Shenzhen JT Automation Equipment Co Ltd
SHE:300400
0.062x
Guangxi Wuzhou Communications Co Ltd
SHG:600368
0.038x
TOA PAINT (THAILAND)
BK:TOA-R
N/A
Beken Corp
SHG:603068
0.014x
Yulon Motor Co Ltd
TW:2201
0.052x
BKS Bank AG
VI:BKS
-0.098x

Annual Cash Flow Conversion Efficiency for Shanghai Runda Med Tech Co (2014–2024)

The table below shows the annual cash flow conversion efficiency of Shanghai Runda Med Tech Co from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Shanghai Runda Med Tech Co.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥5.60 Billion
≈ $820.06 Million
CN¥646.95 Million
≈ $94.67 Million
0.115x -13.83%
2023-12-31 CN¥5.45 Billion
≈ $797.10 Million
CN¥729.72 Million
≈ $106.78 Million
0.134x +256.49%
2022-12-31 CN¥5.01 Billion
≈ $733.10 Million
CN¥-428.86 Million
≈ $-62.76 Million
-0.086x -201.31%
2021-12-31 CN¥4.39 Billion
≈ $642.69 Million
CN¥371.11 Million
≈ $54.31 Million
0.084x +6.59%
2020-12-31 CN¥4.08 Billion
≈ $597.07 Million
CN¥323.44 Million
≈ $47.33 Million
0.079x +13.00%
2019-12-31 CN¥3.52 Billion
≈ $514.56 Million
CN¥246.68 Million
≈ $36.10 Million
0.070x -59.24%
2018-12-31 CN¥3.13 Billion
≈ $458.14 Million
CN¥538.90 Million
≈ $78.86 Million
0.172x +638.52%
2017-12-31 CN¥2.75 Billion
≈ $402.20 Million
CN¥-87.85 Million
≈ $-12.86 Million
-0.032x +43.39%
2016-12-31 CN¥2.22 Billion
≈ $325.17 Million
CN¥-125.47 Million
≈ $-18.36 Million
-0.056x +76.87%
2015-12-31 CN¥928.55 Million
≈ $135.88 Million
CN¥-226.69 Million
≈ $-33.17 Million
-0.244x -421.52%
2014-12-31 CN¥475.63 Million
≈ $69.60 Million
CN¥36.11 Million
≈ $5.28 Million
0.076x --

About Shanghai Runda Med Tech Co

SHG:603108 China Diagnostics & Research
Market Cap
$924.89 Million
CN¥6.32 Billion CNY
Market Cap Rank
#9241 Global
#2300 in China
Share Price
CN¥10.47
Change (1 day)
-0.19%
52-Week Range
CN¥8.83 - CN¥20.04
All Time High
CN¥26.34
About

Shanghai Runda Medical Technology Co., Ltd. provides medical laboratory services primarily in China. It also engages in the research and development, manufacturing, sale, and service of in vitro diagnostic products, including reagents and other consumables; medical solutions to help healthcare professionals in the areas of diabetes, POCT, clinical chemistry, and immunoassay; professional technica… Read more